Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains
about
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosisA second-generation anti TB vaccine is long overdueOral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against TuberculosisEvolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in micePreclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes.Bacillus Calmette-Guérin Suppresses Asthmatic Responses via CD4(+)CD25(+) Regulatory T Cells and Dendritic CellsMice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosisNon-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization.Perspectives on clinical and preclinical testing of new tuberculosis vaccines.Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection.Next generation: tuberculosis vaccines that elicit protective CD8+ T cellsGenomic analysis of a Mycobacterium bovis bacillus [corrected] Calmette-Guérin strain isolated from an adult patient with pulmonary tuberculosis..Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.The Current Status of BCG Vaccination in Young Children in South KoreaEvaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosisMycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells.Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosisDelaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.Low Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability.Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model.Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex.The BCG Strain Pool: Diversity Matters.Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG str"The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease.
P2860
Q24537176-17D53B68-6B27-407B-8434-29222E5DEFCFQ24800887-42E4187C-1D2A-4DFC-B3E2-870A82D065E0Q27313927-FD5BBDF9-3791-40E6-9797-92210427B288Q28083050-BF85FC87-D175-4BB5-A5AF-7527E814696EQ28083377-64A9FFB9-7BEB-4D45-8194-323B3939E4B8Q28218674-324E7C90-2460-4820-BE94-0C312BB0AFB4Q31015281-8AB2CD32-BCC9-44B1-BF14-BC3E8B2930D4Q33369563-AC788FD3-00E1-4AA4-8B6B-8A672B9B85ABQ33444699-76973CE8-9AA6-4E66-A589-AAFB1DE9FD63Q33591737-D357AB2C-AF45-4D06-A5EE-558E96E41947Q33612215-3443E0FA-3B73-4926-BDE2-38F97387ED0BQ33716157-B1810616-0B23-4B13-9C02-E9C7C28B4260Q33791961-A0225EE3-6AB4-4508-A8F7-E8371120D9F7Q33996621-74F22641-C14A-4D49-B939-0BE3C1A80FF0Q34003483-B2378DD5-4A67-4D11-B95D-05B9EDB220CEQ34120343-5CD08297-A691-42B5-BA23-D9B3B4345CFCQ34189865-DFC8A2A4-1A6E-40CE-9317-54536C65447EQ34491796-E44AFA2C-AA19-497B-8715-4F93AE2C9A91Q34595265-8A746465-1B57-4C2D-BA77-44236B998DC9Q35075851-0AB670CD-8E06-4265-9576-F8EE79817ED5Q35099708-506682BA-9281-403F-B615-179D3C268647Q35390426-94AE87DA-0681-426C-9DD2-EEE1D835BA3FQ35913637-E829561A-C15A-466D-832C-19E2805FD414Q36003382-2283AC4D-D5D5-416A-93B1-F73C3B15E55DQ36187495-0419A15D-6DE8-465A-9431-CBFFCF4B84DDQ36434320-6879E1DE-F0FF-457E-8A3E-8E4E567E1608Q36546136-B44CEC03-F8DB-480F-8F22-B89167326F6EQ36617339-A8967281-C26C-4CA3-AAE7-8FBF5CB8F4AFQ37131749-7D96A290-51AA-4601-952C-5744BD33B447Q37350429-DC1F6CE9-7398-41A1-8B7D-FF5068CBFA2DQ37385874-0456F41A-4B9F-4144-8CAD-9C274B278CE3Q38606984-30D8AF6C-1533-4D4C-9FF5-AE8AF087533BQ38862796-8DE8E780-8298-44E5-8313-C52CE87D9D5EQ39555355-18C20128-6ED1-4F04-AD0A-B2D0A12FFDDDQ39788557-4D60A2F9-800D-411E-A9DD-35D58787B404Q39878736-FE8868EA-E643-4E22-A7B2-03EFCAB637B5Q39994755-F24F02D6-1418-4C9D-9E20-850B670F0FA9Q40213126-4DA720E9-8E78-46FE-AE4E-172BF68BE824Q40545635-B51158DD-1A92-4C98-92EB-7E9C4AC5DD5BQ41379320-7B6062E4-61A4-446B-8F59-2AA1878E275B
P2860
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Comparison of immune responses ...... rium bovis BCG vaccine strains
@ast
Comparison of immune responses ...... rium bovis BCG vaccine strains
@en
type
label
Comparison of immune responses ...... rium bovis BCG vaccine strains
@ast
Comparison of immune responses ...... rium bovis BCG vaccine strains
@en
prefLabel
Comparison of immune responses ...... rium bovis BCG vaccine strains
@ast
Comparison of immune responses ...... rium bovis BCG vaccine strains
@en
P2093
P2860
P1476
Comparison of immune responses ...... rium bovis BCG vaccine strains
@en
P2093
Balazuc AM
Gheorghiu M
Lagranderie MR
Leclerc CD
P2860
P407
P577
1996-01-01T00:00:00Z